ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)

CUSIP: 488445206

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
56,066,823
Total 13F shares
8,153,478
Share change
+1,993,469
Total reported value
$41,582,121
Put/Call ratio
44%
Price per share
$5.10
Number of holders
69
Value change
+$9,633,583
Number of buys
42
Number of sells
27

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Samuel J. Braun
3/4/5
10%+ Owner
class O/S missing
3,153,000
$15,636,043 13 May 2021
VANGUARD GROUP INC
13F
Company
2.6%
1,472,793
$8,100,361 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
1.1%
603,178
$3,317,480 31 Mar 2023
13F
Laurion Capital Management LP
13F
Company
1%
571,200
$3,141,600 31 Mar 2023
13F
Janney Montgomery Scott LLC
13F
Company
0.94%
528,755
$2,908,000 31 Mar 2023
13F
GREAT POINT PARTNERS LLC
13F
Company
0.62%
347,824
$1,913,032 31 Mar 2023
13F
Retirement Planning Co of New England, Inc.
13F
Company
0.58%
327,583
$1,801,707 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.57%
319,018
$1,754,599 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.36%
201,172
$1,106,446 31 Mar 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.33%
184,812
$1,016,466 31 Mar 2023
13F
Mystic Asset Management, Inc.
13F
Company
0.32%
177,533
$976,432 31 Mar 2023
13F
Travis C. Mickle
3/4/5
President & CEO, Director
class O/S missing
171,774
$851,845 25 May 2022
MILLENNIUM MANAGEMENT LLC
13F
Company
0.27%
153,053
$842,000 31 Mar 2023
13F
Kovack Advisors, Inc.
13F
Company
0.22%
122,822
$675,521 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.2%
114,626
$630,444 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.2%
110,040
$605,220 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.19%
103,800
$571,000 31 Mar 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
95,143
$523,287 31 Mar 2023
13F
Arete Wealth Advisors, LLC
13F
Company
0.15%
82,290
$453,000 31 Mar 2023
13F
Stratos Wealth Partners, LTD.
13F
Company
0.13%
70,200
$386,100 31 Mar 2023
13F
CITIGROUP INC
13F
Company
0.1%
58,496
$321,728 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.1%
55,708
$306,395 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.1%
53,882
$296,351 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0.09%
49,929
$274,610 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.09%
48,186
$265,023 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.06%
32,831
$180,571 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.06%
31,186
$171,523 31 Mar 2023
13F
Richard W. Pascoe
3/4/5
Chief Executive Officer, Director
class O/S missing
29,973
$148,639 09 Mar 2023
Raymond James Financial Services Advisors, Inc.
13F
Company
0.05%
26,328
$144,804 31 Mar 2023
13F
Squarepoint Ops LLC
13F
Company
0.04%
20,257
$111,414 31 Mar 2023
13F
Jump Financial, LLC
13F
Company
0.03%
19,317
$106,244 31 Mar 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.03%
17,972
$98,846 31 Mar 2023
13F
LPL Financial LLC
13F
Company
0.03%
16,781
$92,296 31 Mar 2023
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.03%
16,747
$92,109 31 Mar 2023
13F
City State Bank
13F
Company
0.03%
14,224
$78,000 31 Mar 2023
13F
Kingsview Wealth Management, LLC
13F
Company
0.02%
12,120
$66,660 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
11,139
$61,265 31 Mar 2023
13F
Lighthouse Investment Partners, LLC
13F
Company
0.02%
10,658
$58,619 31 Mar 2023
13F
David S. Tierney
3/4/5
Director
class O/S missing
10,835
$53,732 09 Mar 2023
Balefire, LLC
13F
Company
0.02%
10,217
$49,859 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
6,225
$34,237 31 Mar 2023
13F
NewEdge Advisors, LLC
13F
Company
0.01%
5,200
$28,600 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
5,077
$27,924 31 Mar 2023
13F
UBS Group AG
13F
Company
0.01%
4,139
$22,765 31 Mar 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
4,137
$22,753 31 Mar 2023
13F
CNB Bank
13F
Company
0.01%
2,938
$16,159 31 Mar 2023
13F
FMR LLC
13F
Company
0%
2,114
$11,628 31 Mar 2023
13F
Stephens Consulting, LLC
13F
Company
0%
2,000
$11,000 31 Mar 2023
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,187
$7,000 31 Mar 2023
13F
Tortoise Investment Management, LLC
13F
Company
0%
1,200
$6,600 31 Mar 2023
13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q2 2023

As of 30 Jun 2023, ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,153,478 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Janney Montgomery Scott LLC, Retirement Planning Co of New England, Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, Mystic Asset Management, Inc., and RENAISSANCE TECHNOLOGIES LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
59
Q2 2023 holders
69
Holder diff
10
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.